The 47 references in paper I. Komarov G., I. Poddubnaya V., M. Nemtsova V., N. Levitskaya V., V. Lewitzki , V. Lewitzki, И. Комаров Г., И. Поддубная В., М. Немцова В., Н. Левицкая В. (2015) “CUP-СИНДРОМ: СОВРЕМЕННЫЙ ВЗГЛЯД НА ПРОБЛЕМУ (ОБЗОР ЛИТЕРАТУРЫ) // CUP-SYNDROME: THE PRESENT VIEW OF THE PROBLEM (A REVIEW OF LITERATURE)” / spz:neicon:modonc:y:2013:i:1:p:45-49

1
Комаров И.Г., Комов Д.В. Метастазы злокачественных опухолей без выявленного первичного очага. Энциклопедия клинической онкологии. М.: РЛС, 2004.
(check this in PDF content)
2
Минимальные клинические рекомендации Европейского общества медицинской онкологии. М., 2008.
(check this in PDF content)
3
Abbruzzese JL, Abbruzzese MC, Hess KR. Unknown primary carcinoma: natural history and prognostic factors in 657 consecutive patients. J Clin Oncol 1994; 12: 1272–80.
(check this in PDF content)
4
Abeloff MD, Armitage JO, Lichter AS et al. Unknown primary in clinical oncology. Churchill Livingstone. NY 1995; p. 1833–45.
(check this in PDF content)
5
Altman E, Cadman E. An analysis of 1539 patients with cancer of unknown primary site. Cancer 1986; 57 (1): 120–4.
(check this in PDF content)
6
Bar-Eli M, Abbruzzese JL, Lee-Jackson D et al. P53 gene mutation spectrum in human unknown primary tumors. Anticancer Res 1993; 13: 1619–23.
(check this in PDF content)
7
Bloom G, Yang IV, Boulware D et al. Multi-platform, multi-site, microarray-based human tumor classification. Am J Pathol 2004; 164: 9–16.
(check this in PDF content)
8
Briasoulis E, Tsokos M et al. Bcl-2 and p53 protein expression in metastatic carcinoma of unknown primary origin. Biological and clinical implications. A Hellenic Cooperative Oncology Group study. Anticancer Res 1998; 18: 1907–14.
(check this in PDF content)
9
Chevalier TL, Cvitkovic E, Caille P. Early metastatic cancer of unknown primary origin at presentation. A clinical study of 302 consecutive autopsied patients. Arch Intern Med 1988; 148: 2035–9.
(check this in PDF content)
10
Chorost MI, Lee MC, Yeoh CB. Unknown primary. J Surg Oncol 2004; 87: 191–203.
(check this in PDF content)
11
Culine S, Kramar A, Saghatchian M et al. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site. J Clin Oncol 2002; 20 (24): 4679–83.
(check this in PDF content)
12
Gaast A, Verweij J, Planting AS et al. Fluorouracil, doxorubicin and mitomycin C: (FAM) combination chemotherapy for metastatic adenocarcinoma of unknown primary. Eur J Cancer Clin Oncol 1988; 24 (4): 765–8.
(check this in PDF content)
13
Greco FA, Hainsworth JD. Tumors of unknown origin. Cancer J Clin 1992; 42: 96–115.
(check this in PDF content)
14
Greco FA. Cancer of unknown primary site: evolving understanding and management of patients. Clin Advanc Hematol Oncol 2012; 10 (8): 518–24.
(check this in PDF content)
15
Haldar S, Basu A, Croce CM. Bcl-2 is the guardian of microtubule integrity. Cancer Res 1997; 57: 229–33.
(check this in PDF content)
16
Hillen HF. Unknown primary tumours review. Postgrad Med J 2000; 76: 690–3.
(check this in PDF content)
17
Hollstein M, Sidransky D, Vogelstein B. P53 mutations in human cancers. Science 1991; 253: 49–53.
(check this in PDF content)
18
Ilson DH, Motzer RJ, Rodriguez E et al. Genetic analysis in the diagnosis of neoplasms of unknown primary tumor site. Semin Oncol 1993; 20: 229–37.
(check this in PDF content)
19
Kirsten F, Chi CH, Leary JA. Metastatic adeno or undifferentiated carcinoma from unknown primary site – natural history and guidelines for identification of treatable subsets. Q J Med 1987; 62: 143–61.
(check this in PDF content)
20
Krämer A, Gattenlöhner S, Neben K. CUP-Syndrom. Molekulare pathogenese und biologie pathologe 2009; 30: 117–24.
(check this in PDF content)
21
Lembersky BC, Thomas LC. Metastases of unknown primary site. Med Clin North Am 1996; 80 (1): 153–71.
(check this in PDF content)
22
Leonard RJ, Nystrom JS. Diagnostic evaluation of patients with carcinoma of unknown primary site. Semin Oncol 1993; 20: 244–50.
(check this in PDF content)
23
Levi F, Te VC et al. Epidemiology of unknown primary tumour. Eur J Cancer 2002; 38: 1890–12.
(check this in PDF content)
24
Moll R. Initial CUP-Situation und CUP-Syndrom Pathologische Diagnostik. Pathologe 2009; 30 (Suppl. 2): 161–7.
(check this in PDF content)
25
Motzer RJ, Rodriguez E, Reuter VE et al. Molecular and cytogenetic studies in the diagnosis of patients with poorly differentiated carcinomas of unknown primary site. J Clin Oncol 1995; 13: 274–82.
(check this in PDF content)
26
Nissenblatt MJ. Carcinoma with unknown primary tumor (CUP syndrome). South Med J 1981; 74: 1497–502.
(check this in PDF content)
27
Nystrom JS, Weiner JM, Heffelfinger-Juttner J. Metastatic and histologic presentation in unknown primary cancer. Semin Oncol 1997; 4: 53–8.
(check this in PDF content)
28
Pantou D, Tsarouha H, Papadopoulou A. Cytogenetic profile of unknown primary tumors: clues for their pathogenesis and clinical management. Neoplasia 2003; 5: 23–31.
(check this in PDF content)
29
Pavlidis N, Briasoulis E, Hainsworth J. Diagnostic and therapeutic management of cancer of an unknown primary. Eur J Cancer 2003; 39: 1990–2005.
(check this in PDF content)
30
Pavlidis N. Forty years experience of treating cancer of unknown primary. Acta Oncol 2007; 46: 592–601.
(check this in PDF content)
31
Pavlidis N, Wick MR. Metastatic carcinomas of unknown primary origin. Chemotherapy NY. Demos Medical Publishing 2008; p. 225–34.
(check this in PDF content)
32
Pavlidis N, Fizazi K. Carcinoma of unknown primary (CUP) critical reviews. Oncol Hematol 2009; 69: 271–8.
(check this in PDF content)
33
Pavlidis N, Pentheroudakis G. Cancer of unknown primary site: 20 questions to be answered. Ann Oncol 2010; 21 (7): 303–7.
(check this in PDF content)
34
Pavlidis N, Pentheroudakis G. Cancer of unknown primary site. Lancet 2012; 379: 1428–5.
(check this in PDF content)
35
Pentheroudakis G, Briasoulis E, Pavlidis N. Cancer of unknown primary site: missing primary or missing biology. Oncologist 2007; 12: 418–25.
(check this in PDF content)
36
Petersen I, Hidalgo A, Petersen S. Chromosomal imbalances in brain metastases of solid tumors. Brain Pathol 2000; 10: 395–401.
(check this in PDF content)
37
Rosenfeld N, Aharonov R, Meiri E et al. Micro RNAs accurately identify cancer tissue origin Nat Biotechnology 2008; 26: 462–9.
(check this in PDF content)
38
Soong R, Robbins PD, Dix BR et al. Concordance between p53 protein overexpression and gene mutation in a large series of common human carcinomas. Hum Pathol 1996; 27: 1050–5.
(check this in PDF content)
39
Su AI, Welsh JB, Sapinoso LM et al. Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001; 61: 7388–93.
(check this in PDF content)
40
Summersgill B, Goker H, Osin P et al. Establishing germ cell origin of undifferentiated tumors by identifying gain of 12p material using comparative genomic hybridization analysis of paraffin-embedded samples. Diagn Mol Pathol 1998; 7: 260–6.
(check this in PDF content)
41
Tothill RW, Kowalczyk A, Rischin D et al. An expression-based site of origin diagnostic method designed for clinical application to cancer of unknown origin. Cancer Res 2005; 65: 4031–40.
(check this in PDF content)
42
Varadhachary GR, Abbruzzese JL, Lenz R. Diagnostic strategies for unknown primary cancer. Cancer 2004; 100: 1776–85.
(check this in PDF content)
43
Visser O, Coebergh JW, Schouten LJ. Incidence of cancer in the Netherlands. Netherlands Cancer Registry Utrecht 1993.
(check this in PDF content)
44
Vousden KH, Woude GF. The ins and outs of p5. Nat Cell Biol 2000; p. 178–80.
(check this in PDF content)
45
Wouw AJ, Janssen-Heijnen ML Coebergh JW. Epidemiology of unknown primary tumours; incidence and population-based survival of 1285 patients in Southeast Netherlands 1984–1992. Eur J Cancer 2002; 3: 409–13.
(check this in PDF content)
46
Wouw AJ, Jansen RL, Speel EJ. The unknown biology of the unknown primary tumour: a literature review. Ann Oncol 2003; 14: 191–6.
(check this in PDF content)
47
Wouw AJ, Jansen RL, Griffioen AW. Clinical and Immunohistochemical analysis of patients with unknown primary tumour. A search for prognostic factors in UPT. Anticancer Research 2004; 24: 297–302.
(check this in PDF content)